Gout incidence down with SGLT2 inhibitors in type 2 diabetes
Adults with type 2 diabetes newly prescribed a sodium-glucose cotransporter-2 (SGLT2) inhibitor have a lower incidence of gout than those prescribed a glucagon-like peptide-1 (GLP-1) receptor agonist, according to a study ...
Jan 14, 2020
0
2